Neonatal abstinence syndrome (NAS) is a complex of symptoms that occurs in newborns when the mother stops using addictive substances during pregnancy. The most common causes are drug abuse, including opioids, and the use of alcohol and other psychoactive substances. Symptoms can appear in the first days of life and include increased irritability, shaking, sleep disturbances, hyperactivity, seizures, feeding problems, and even breathing difficulties. This syndrome requires careful diagnosis and treatment, as susceptibility to it can vary depending on many factors, such as the type of substance, duration of use, and individual characteristics of the mother.
History of the disease and interesting historical facts
Neonatal abstinence syndrome was first described in 1975, when researchers noted an association between women using opioid drugs during pregnancy and withdrawal symptoms in their newborns. However, cases similar to NAS had been observed long before that, when drug use became more widespread. In the 1980s, public awareness of drug addiction increased significantly, leading to greater understanding of its effects on pregnant women and their babies. Since then, various classifications and criteria for diagnosis have been developed, leading to a better understanding of the syndrome and its treatment.
Epidemiology
According to the Centers for Disease Control and Prevention (CDC), the incidence of neonatal abstinence syndrome in the United States has increased significantly over the past two decades. In 2000, the incidence of the syndrome was approximately 1 in 1,000 newborns, and by 2017, this rate had increased to 7 in 1,000 newborns. Recent research shows that areas with high rates of opioid abuse often have high rates of NAS. Recent data show that in some states, the syndrome occurs in 10-20% newborns. Notably, the risk of developing NAS is higher in mothers who have used more than one type of drug.
Genetic predisposition to this disease
Genetic predisposition to neonatal abstinence syndrome is a subject of active study. Research suggests that certain genetic markers may increase the risk of drug dependence in mothers and, consequently, the likelihood of neonatal abstinence syndrome. In particular, variants in genes involved in opioid metabolism, such as OPRM1 (the opiate receptor μ gene), may influence the severity of dependence. Additionally, mutations in genes involved in neurotransmitter transport may also play a significant role.
Risk factors for the development of this disease
Risk factors for neonatal abstinence syndrome fall into several categories, including physical, chemical, and social.
- Physical factors: chronic maternal diseases (eg, HIV, hepatitis); preterm birth and low birth weight of the newborn.
- Chemical factors: maternal use of opioid drugs, alcohol, antidepressants, benzodiazepines.
- Social factors: lack of social and emotional support, living conditions, level of education and economic factors.
These factors can, either independently or in combination, influence the risk of developing the syndrome in newborns.
Diagnosis of this disease
Diagnosis of neonatal abstinence syndrome is based on clinical manifestations, multiple laboratory tests and observations of the newborn.
- Main symptoms: increased excitability, shaking, sleep disturbances, feeding difficulties, convulsions, high sensitivity to sounds and light.
- Laboratory tests: tests for the presence of narcotic substances in the blood and urine of the newborn.
- Radiological examinations: in rare cases, they are performed to exclude other pathologies, for example, X-ray examinations.
- Other types of diagnostics: assessment of the functional state of the newborn using the Finnegan scale to determine the severity of symptoms.
- Differential diagnosis: It is important to distinguish between NAS and other conditions such as infections, neurological disorders and metabolic disorders.
Treatment
Treatment of neonatal abstinence syndrome should be comprehensive and include both general approaches, such as supporting breastfeeding and creating a comfortable environment, and specific drug interventions.
- General treatment: providing a warm and comfortable environment, minimizing external stimuli, ensuring a suitable sleep regimen.
- Pharmacological treatment: using opioids such as morphine or methadone to relieve withdrawal symptoms.
- Surgical treatment: usually not used, but may be relevant in cases of concomitant pathologies.
- Other treatments: Non-narcotic analgesics and sedatives may be used to help relieve the condition.
List of medications used to treat this disease
The main drugs used to treat neonatal abstinence syndrome include:
- Morphine
- Methadone
- Buprenorphine
- Clonazepam (sometimes if symptoms are severe)
- Phenobarbital
It is important to note that the choice of drug depends on the severity of the syndrome and the individual condition of the newborn.
Disease monitoring
Monitoring the condition of newborns with neonatal abstinence syndrome includes regular assessments of symptoms, monitoring the effectiveness of treatment, and identifying possible complications.
- Control stages: regular assessment of the patient's condition using scales for assessing the degree of abstinence, identification of deviations from the norm.
- Prognosis: With timely and adequate treatment, most children recover without long-term consequences.
- Complications: In rare cases, long-term neurological or behavioral problems may occur, requiring additional interventions.
Age-related features of the disease
Neonatal abstinence syndrome is predominantly seen in newborns, but its manifestations may vary depending on age.
- Newborns (0-28 days): classic withdrawal symptoms requiring careful management.
- Older children: In some cases, behavioral and emotional disturbances may occur that require additional monitoring and intervention.
In all age groups, the focus is on maintaining normal development and minimizing negative consequences.
Questions and Answers
- What is neonatal abstinence syndrome? Neonatal abstinence syndrome is a condition caused by the cessation of the supply of psychoactive substances used by the mother during pregnancy to the newborn's body.
- What are the main symptoms of NAS? The main symptoms are increased excitability, seizures, feeding problems, sleep disturbances and shaking.
- What factors increase the risk of developing NAS? Major risk factors include maternal use of opioids, alcohol, and other drugs, as well as socioeconomic conditions.
- What diagnostic methods are used to detect NAS? Diagnosis is made using clinical observations, laboratory tests and symptom assessment scales.
- How is neonatal abstinence syndrome treated? Treatment includes creating a comfortable environment, using morphine or other drugs to relieve symptoms, and supporting breastfeeding.
